Open original FDA record ↗Recall record
- FDA identifier
- Z-0148-2027
- Company in FDA record
- BioFire Diagnostics, LLC
- FDA classification date
- Oct 13, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to potential contaiminated of spefic lots of pneumonia and joint infection panels that could result in false positive results
Source facts
- Action
- On 09/03/2026, an "URGENT: MEDICAL DEVICE RECALL (CORRECTION)" Letter was emailed to customers informing them that, bioMrieux internally identified increased rates of KPC unexpected positives in Quality Control (QC) testing of the BIOFIRE FILMARRAY PN Panel, BIOFIRE FILMARRAY PNplus Panel, and BIOFIRE JI Panel. Internal testing reproduced KPC unexpected positive results, suggesting KPC nucleic acid contamination in reagent manufacturing at levels that can lead to false positive results. Customers are instructed to: " Examine inventory for the lots identified in this recall. " If a positive KPC result obtained when using the affected product is inconsistent with local resistance epidemiology and clinical data, then the result should be confirmed with an alternative method. " If customer has further distributed or transferred this product to another facility, identify any recipients, notify them at once, and forward this notice. " Post the recall (correction) letter on or near affected products as a constant reminder of the actions that need to be taken. " Complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux so that bioMrieux may acknowledge your receipt of this notification. For questions - contact your local Customer Service Representative at 1-800-682-2666, selecting option 1 for Technical Support and option 3 for BIOFIRE, or email biofiresupport@biomerieux.com
- Initiated
- 2026-08-12
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide - U.S. Nationwide distribution including in the states and territory of AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY. The countries of United Arab Emirates, Netherland Antilles, Argentina, Austria, Bosnia and Herzegovina, Belgium, Bulgaria, Bolivia, Canada, Switzerland, Chile, China, Colombia, Costa Rica, Czech Republic, Germany, Denmark, Dominican Republic, Algeria, Ecuador, Spain, Finland, France, United Kingdom, Greece, Guatemala, Hong Kong, Honduras, Croatia, Hungary, Indonesia, Israel, India, Italy, Japan, Korea, Lebanon, Sri Lanka, Lithuania, Mexico, Malaysia, Nicaragua, Panama, Peru, Philippines, Poland, Portugal, Paraguay, Romania, Serbia, Singapore, El Salvador, Thailand, Taiwan, Venezuela, Vietnam.
- Recall number
- Z-0148-2027
- Recall status
- Open, Classified
- CDRH record ID
- 221921
- FDA classified
- 2026-10-13
- Recall event number
- 99592